17 August 2022
Q&A with CEO Jonathan Thon featured in Inside Precision Medicine

26 July 2022
STRM.BIO Receives $2.1 Million SBIR Grant to Advance Extracellular Vesicle Technology for Non-Viral, In Vivo Delivery of Gene Therapies

13 June 2022
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development

19 January 2022
STRM.BIO recruits technology leader to help bring gene therapy to life